Vericel Corp Uncategorized Contracts & Agreements
38 Contracts & Agreements
- Fourth Amendment to the Dispensing Agreement between AllCare Plus Pharmacy, Inc. and the Company, dated June 1, 2024 (Filed With SEC on August 1, 2024)
- Third Amendment to the Dispensing Agreement between AllCare Plus Pharmacy, Inc. and the Company, dated May 16, 2022 (Filed With SEC on August 3, 2022)
- First Amendment to Dispensing Agreement by and between AllCare Plus Pharmacy and the Company, dated May 1, 2019 (Filed With SEC on August 6, 2019)
- Dispensing Agreement by and between AllCare Plus Pharmacy and the Company, dated July 26, 2018 (Filed With SEC on November 6, 2018)
- Amendment No. 5 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated December 5, 2017 (Filed With SEC on December 28, 2017)
- Amendment No. 4 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated November 9, 2017 (Filed With SEC on December 28, 2017)
- Amendment No. 3 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated October 9, 2017 (Filed With SEC on December 28, 2017)
- Amendment No. 2 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated September 5, 2017 (Filed With SEC on November 7, 2017)
- Amendment No. 1 to Side Letter between Vericel Corporation and Innovative Cellular Therapeutics CO., LTD., dated August 3, 1017 (Filed With SEC on November 7, 2017)
- * * * * * (Filed With SEC on June 2, 2017)
- CONFIDENTIAL AND PROPRIETARY TO PPD (Filed With SEC on December 30, 2016)
- 64 Sidney Street Cambridge, Massachusetts LANDLORD FC 64 SIDNEY, INC. TENANT GENZYME CORPORATION Table of Contents (Filed With SEC on March 14, 2016)
- 64 Sidney Street Cambridge, Massachusetts LANDLORD FC 64 SIDNEY, INC. TENANT GENZYME CORPORATION TABLE OF CONTENTS (Filed With SEC on March 14, 2016)
- RESIGNATION AGREEMENT (Filed With SEC on March 18, 2013)
- CONFIDENTIAL AND PROPRIETARY TO [ * * * ] (Filed With SEC on November 22, 2011)
- AASTROM BIOSCIENCES, INC. (Filed With SEC on June 16, 2011)
- AASTROM BIOSCIENCES, INC. (Filed With SEC on August 31, 2010)
- BYLAWS OF AASTROM BIOSCIENCES, INC. (Filed With SEC on October 23, 2008)
- CURRENT ASSETS (Filed With SEC on May 12, 2008)
- AGREED AND ACCEPTED: Name of Investor: Name Title: Address: DWAC Number: AASTROM BIOSCIENCES, INC. By: Name: Title: (Filed With SEC on October 16, 2007)
- CURRENT ASSETS (Filed With SEC on February 9, 2007)
- CURRENT ASSETS (Filed With SEC on February 9, 2006)
- CURRENT ASSETS (Filed With SEC on February 9, 2006)
- Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction (Filed With SEC on September 13, 2005)
- Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction (Filed With SEC on September 13, 2005)
- Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction (Filed With SEC on September 13, 2005)
- Local bone regeneration such as is needed in fractures, spinal fusion, and jaw bone reconstruction (Filed With SEC on September 13, 2005)
- CURRENT ASSETS (Filed With SEC on November 9, 2004)
- CURRENT ASSETS (Filed With SEC on November 9, 2004)
- Local bone regeneration in fractures, spinal fusion and jaw bone reconstruction for dental implants (Filed With SEC on September 13, 2004)
- Engagement Agreement dated March 19, 2004 by and between the Company and Jesup & Lamont Securities Corporation (Filed With SEC on April 2, 2004)
- LEGAL PROCEEDINGS (Filed With SEC on September 9, 2003)
- LEGAL PROCEEDINGS (Filed With SEC on September 9, 2003)
- LEGAL PROCEEDINGS (Filed With SEC on September 9, 2003)
- LEGAL PROCEEDINGS (Filed With SEC on September 9, 2003)
- LEGAL PROCEEDINGS (Filed With SEC on September 30, 2002)
- LEGAL PROCEEDINGS (Filed With SEC on September 30, 2002)
- LEGAL PROCEEDINGS (Filed With SEC on September 30, 2002)
